Literature DB >> 1997597

Propranolol for treatment of agitation in senile dementia.

M E Pauszek.   

Abstract

Agitated and disruptive behavior is a common complication of senile dementia. Therapy with antipsychotic and anxiolytic agents is frequently unsuccessful and problematic. Though there are no controlled studies, Propranolol, the non-specific beta blocker, suppresses agitated behavior in patients with senile dementia.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1997597

Source DB:  PubMed          Journal:  Indiana Med        ISSN： 0746-8288


  5 in total

Review 1.  Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.

Authors:  Aaron M Koenig; Steven E Arnold; Joel E Streim
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

2.  Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients.

Authors:  A Russo-Neustadt; C W Cotman
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 3.  Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Authors:  Michael J Passmore; David M Gardner; Yvette Polak; Kiran Rabheru
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.

Authors:  Mary Gannon; Qin Wang
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

Review 5.  Noradrenergic dysfunction in Alzheimer's disease.

Authors:  Mary Gannon; Pulin Che; Yunjia Chen; Kai Jiao; Erik D Roberson; Qin Wang
Journal:  Front Neurosci       Date:  2015-06-17       Impact factor: 4.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.